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Abstract 
Background 
Maintaining sinus rhythm in patients with non-paroxysmal atrial fibrillation (AF) is an elusive goal.  
Some suggest that hybrid ablation, combining minimally-invasive epicardial surgical ablation with 
endocardial catheter ablation, may be more effective than either modality alone.  However, 
randomised trials are lacking.   
Objectives 
We investigated whether hybrid ablation is more effective than epicardial ablation alone at 
preventing recurrent AF by performing a systematic review and meta-analysis. 
Methods 
The review was prospectively registered with PROSPERO (CRD42016043389).  MEDLINE and EMBASE 
were searched for studies of standalone minimally invasive epicardial ablation of AF and/or hybrid 
ablation, identifying 41 non-overlapping studies comprising 2737 patients.   A random-effects meta-
analysis, meta-regression, and sensitivity analysis were performed. 
Results 
Single-procedure survival free from atrial arrhythmias without antiarrhythmic drugs (AADs) was 
similar between epicardial-alone and hybrid approaches at 12 (epicardial-alone 71.5%, 95% 
confidence intervals (CI) 66.1-76.9%; hybrid 63.2%, CI 51.5-75.0%) and 24 months (epicardial-alone 
68.5%, CI 57.7-79.3%; hybrid 57.0%, CI 33.6-80.4%).  Freedom from atrial arrhythmias with AADs and 
rates of unplanned additional catheter ablations were also similar between groups.  Major 
complications occurred more often with hybrid ablation (epicardial-alone 2.9%, CI 1.9-3.9%; hybrid 
7.3%, CI 4.2-10.5%).  Meta-regression suggested that bipolar radiofrequency energy and 
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thoracoscopic access were associated with greater efficacy, but adjusting for these factors did not 
unmask any difference between epicardial-alone and hybrid ablation. 
Conclusions 
Hybrid and epicardial ablation alone appear to be equally effective treatments for AF, although 
hybrid ablation may be associated with higher complication rates.  This data derived from 
observational studies should be verified with randomised data.  
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Clinical perspective 
 Maintenance of sinus rhythm is difficult to achieve in patients with persistent or 
longstanding persistent atrial fibrillation. 
 Minimally invasive surgical ablation offers a 70% chance of freedom from atrial arrhythmias 
at 12 months, at the cost of a complication rate of 2-10% depending on the technique used. 
 Hybrid ablation is no more effective than epicardial ablation alone but is associated with a 
higher rate of major complications. 
 While left atrial appendage exclusion is associated with higher success rates, lesion sets 
more extensive than pulmonary vein isolation do not improve outcomes. 
 Transdiaphragmatic access and monopolar energy source are associated with inferior 
outcomes. 
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Abbreviations 
AF = atrial fibrillation 
RCT = randomized controlled trial 
RF = radiofrequency 
AADs = anti-arrhythmic drugs 
CI = confidence interval 
OR = odds ratio 
  
8 
 
 
Introduction 
The goal of arrhythmia eradication in atrial fibrillation (AF) continues to be elusive for cardiac 
electrophysiologists.  Although endocardial radiofrequency (RF) catheter ablation is more effective 
than pharmacological management at maintaining sinus rhythm1, it is far from perfect, especially in 
patients with non-paroxysmal AF2.  In an attempt to address this, attention has turned back to the 
surgical ablation that preceded catheter-based approaches.  While the initial open-chest Cox-MAZE 
procedure generated high success rates, the complexity and invasiveness of this procedure limited 
its widespread adoption.  As surgical techniques evolved and the traditional cut-and-sew method of 
surgical ablation was replaced with device-based lesion formation, the complication rate 
substantially improved3.  Aiming to preserve efficacy while reducing complication rates and recovery 
time, several minimally invasive surgical techniques have been described varying in access site, 
ablation energy source, and lesion set.  These aims may not have been fully met, as a recent review 
found that that using modern techniques, a full Cox-Maze performed on cardiopulmonary bypass 
had an equally low complication rate as minimally invasive procedures3. 
Initial reports suggest that minimally invasive epicardial surgical ablation may be more effective than 
endocardial catheter ablation4-6, albeit with a higher risk of complications.  Why should ablation 
from the epicardial surface be more effective?  Epicardial ablation using bipolar RF increases the 
likelihood of fully transmural atrial lesions which reduce the chance of electrical reconnection7, 
although transmural lesions occur less frequently using monopolar RF8.  Furthermore, the left atrial 
appendage can be both physically and electrically isolated during surgical ablation, reducing the risk 
of thromboembolism and possibly recurrent arrhythmias9.  The disadvantages of surgical ablation 
relate to difficulties accessing some regions of the atria (the cavotricuspid and mitral isthmuses, and 
the superior aspect of the pulmonary veins with a transdiaphragmatic approach).  These regions are 
however, easily accessible by endocardial catheter ablation.  To exploit the benefits of epicardial and 
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endocardial ablation, some groups therefore advocate a ‘hybrid’10 or ‘convergent’11  approach and 
routinely combine these techniques. 
Despite the theoretical advantages of a hybrid approach, it is uncertain whether hybrid ablation is 
more effective than epicardial ablation alone in practice as no randomised controlled trials (RCTs) 
have addressed this question.  While a single cohort study suggested that hybrid ablation was more 
effective 12, two others did not find a difference13,14, potentially stemming from differences in the 
surgical techniques and lesions sets used. 
We asked whether, in patients with AF, the outcomes from hybrid ablation differ from those from 
minimally invasive surgical epicardial ablation alone with respect to freedom from atrial arrhythmias 
at 12 and 24 months, major complication rate, and need for additional unplanned catheter 
ablations.  Due to the absence of RCTs, we addressed these questions by performing a systematic 
review and meta-analysis of all studies reporting the outcomes of these procedures. 
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Methods 
A comprehensive description of the methods used can be found in the supplemental materials.  The 
PRISMA15 and MOOSE16 guidelines for reporting meta-analyses were followed.  A protocol for the 
meta-analysis was prospectively recorded in the PROSPERO registry (CRD42016043389). 
Search strategy 
Relevant studies were identified by interrogating the MEDLINE and EMBASE databases including 
studies from the start of records to 1st November 2016.  Additional studies were identified by 
scanning reference lists of included studies and existing reviews.  The search strategy can be found 
in Figure 1.  Shortlisted papers and reasons for exclusion can be found in the Supplemental 
Materials. 
Outcome measures 
The pre-specified primary outcome was survival free from any atrial arrhythmia (AF, typical or 
atypical atrial flutter, left or right atrial tachycardia) without antiarrhythmic drugs (AADs) at 12 and 
24 months.  Secondary outcomes included survival free from any atrial arrhythmias with or without 
AADs, survival free from AF with or without AADs, need for repeat catheter ablation, and rate of 
major complications.    
Eligibility and exclusion criteria 
RCTs, cohort studies and case series published in peer-reviewed journals including at least one 
cohort of ≥10 patients undergoing minimally invasive epicardial ablation of AF using radiofrequency 
energy were eligible for inclusion.   Studies were excluded if patients underwent concomitant cardiac 
surgery or routine sternotomy, used non-radiofrequency energy sources, were not published as full-
text articles, or contained patients overlapping an already included study.   
Studies in which the planned treatment was a combination of minimally invasive surgical ablation 
with endocardial catheter ablation, and in which both aspects of the ablation were completed in 
11 
 
 
>75% of patients, were included in the ‘hybrid’ group.  The endocardial ablation could be performed 
either simultaneously with the epicardial ablation or as a staged procedure up to three months later, 
as no difference in outcome has been shown between simultaneous and staged hybrid ablation17.   
Studies in which catheter ablation was not performed routinely but was performed ad hoc in cases 
of recurrent arrhythmia were included in the ‘epicardial only’ group.  Studies that fell into neither of 
these categories were excluded. 
Statistical methods 
Data analysis was performed by a statistician (LB).  Based on the sampling frame which comprises 
diverse populations of patients, pooled estimates were obtained for each outcome for epicardial-
alone and hybrid ablation via the DerSimonian and Laird method using a random-effects model.  
Differences between epicardial-alone and hybrid ablations were judged to be different if 95% 
confidence intervals for the respective pooled estimates did not overlap18.  Baseline demographics 
were compared using two-tailed T-tests for normally distributed continuous data and Chi-squared 
tests for categorical data.  Meta-regression was used to examine the impact of several clinical 
covariates on the effect size of both primary outcomes.   Study quality and risk of bias within studies 
were assessed using a modified version of published criteria1,19 for measuring the quality of case 
series (Supplemental Table 3).  Risk of publication bias across studies was assessed using Funnel 
plots and Eggers’ test18.  Analyses were performed using R version 3.2.320.   
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Results 
The search strategy detailed above generated 1636 abstracts (Figure 1).  41 studies containing a 
total of 2737 patients met the inclusion criteria (median patients per study 52, range 12-240).  The 
commonest reason for excluding studies was overlapping patient cohorts (Supplemental Table 4).  
Five RCTs and two cohort studies compared minimally invasive surgical ablation against another 
treatment (catheter ablation4-6,21 (n=4), medical management22,23 (n=2), open chest surgical 
ablation24 (n=1); in these studies the minimally invasive surgical arm was treated as a single case 
series.  Two RCTs and one cohort study compared surgical ablation techniques (+/- ganglionic plexus 
ablation25 (n=1), +/- left atrial appendage exclusion26 (n=1), immediate vs. delayed hybrid ablation17 
(n=1); in these studies the two arms were combined to form a single case series for the primary 
analysis but treated as separate series for the meta-regression where appropriate.   One cohort 
study compared hybrid with epicardial-alone ablation13 and in this study the two arms treated as 
separate case series.  30 studies were single-arm case series.  41 studies therefore yielded 42 case 
series. 
Combined, the demographics of the patients included in the studies of epicardial ablation alone 
were broadly similar to those included in the studies of hybrid ablation (Table 1).  However, studies 
of hybrid ablation included patients with greater left atrial diameters, a greater proportion of 
patients with longstanding persistent AF and correspondingly fewer patients with paroxysmal AF.  
These discrepancies were addressed and adjusted for in sensitivity analyses. 
Clinical outcomes 
Studies showed heterogeneity across all outcomes and therefore a random-effects model was used.  
The pooled estimates for the pre-specified primary outcome of survival free from any atrial 
arrhythmias without AADs showed marked heterogeneity, but were similar between epicardial-
alone and hybrid approaches at 12 months (epicardial-alone 71.5%, CI 66.1-76.9%, I2 86%; hybrid 
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63.2%, CI 51.5%-75.0%, I2 89%; Figure 2A) and 24 months (epicardial-alone 68.5%, CI 57.7-79.3%, I2 
87%; hybrid 57.0%, CI 33.6-80.4%, I2 92%; Figure 2B). 
Survival free from any atrial arrhythmias with or without AADs was also similar at 12 months 
(epicardial-alone 78.4%, CI 72.9-83.9%, I2 87%; hybrid 76.9% CI 66.6-87.3%, I2 90%, Supplemental 
Figure 1) and 24 months (epicardial-alone 77.1%, CI 67.5-86.6%, I2 82%; hybrid 65.2%, CI 39.0-91.4%, 
I2 95%, Supplemental Figure 2), as was  AF-free survival with or without AADs at 12 months 
(epicardial-alone 77.4%, CI 64.3-90.6%, I2 87%; hybrid 90%, CI 83.0-97.1%, I2 90%, Supplemental 
Figure 3) and 24 months (epicardial-alone 87.2%, CI 81.2-93.3%, I2 0%; hybrid 93.1%, CI 87.2-99%, I2 
0%, Supplemental Figure 4). 
The rate of major complications defined as a composite of death, stroke/TIA, major bleeding, 
pericardial effusion requiring drainage, atrio-oesophageal fistula, and sternotomy showed somewhat 
narrower heterogeneity than the primary outcome, and was significantly higher in the hybrid 
ablation group (epicardial-alone 2.8%, CI 1.8-3.9%, I2 52%; hybrid 7.3%, CI 4.2-10.5%, I2 54%, 
Supplemental Figure 5, Supplemental Table 7).   
Similar numbers of additional unplanned catheter ablations were performed in each group 
(epicardial-alone 7.2%, CI 4.9-9.6%, I2 51%; hybrid 7.1%, CI 2.8-11.4%, I2 81%, Supplemental Figure 
6).   
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Meta-regression 
We next explored possible causes for the marked heterogeneity in reported success rates by 
performing a univariable meta-regression on the primary outcome (Table 2). 
Studies using monopolar RF reported lower success rates than those using bipolar RF (odds ratio 
(OR) 0.79, CI 0.70-0.88 at 12 months).  Lower success rates were also seen when transdiaphragmatic 
access was compared to thoracoscopic access (OR 0.72, CI 0.61-0.86 at 12 months). 
We investigated the surgical techniques used by grouping studies according to primary lesion set 
(PVI, PVI and box lesion, PVI and box lesion and RA ablation), ganglionic plexus ablation, left atrial 
appendage exclusion, and whether conduction block was verified.  Studies in which >50% of 
participants underwent left atrial appendage exclusion reported higher success rates (OR 1.15, 1.04-
1.27 at 12 months).  Neither the proportion of participants with paroxysmal AF nor the duration of 
ambulatory monitoring in the first 12 months were associated with the primary outcome. 
We also performed a metaregression on the major complication rate (Table 1).  Higher rates of 
major complications were associated with hybrid ablation (OR 1.03, 1.01-1.05), transdiaphragmatic 
access (OR 1.05, 1.00-1.11), more extensive lesion sets (OR 1.04, 1.02-1.06 for PVI alone vs. PVI and 
box lesion and RA ablation), and left atrial appendage exclusion (OR 1.03. 1.01-1.05).   
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Sensitivity analysis 
As our primary analysis suggested that hybrid ablation was no more effective than epicardial 
ablation alone, we next performed sensitivity analyses to assess the robustness of our conclusions 
(Supplemental Table 8). 
We first addressed the disparity in demographics by performing a sensitivity analysis including only 
studies in which no more than 20% of participants had paroxysmal AF, a value which in our 
experience is representative of the case mix of thoracoscopic ablation in the UK27.  This analysis 
removed all demographic differences including the proportion of participants with paroxysmal AF 
(epicardial-alone 1.8%, CI 0-6.8%, hybrid 3.3% CI  0-9.1%, p=0.55) and mean left atrial diameter 
(epicardial-alone 49.3mm, CI 44.5-54.1mm, hybrid 49.1mm, CI 46.7-51.7, p=0.88).  This analysis did 
not unmask any differences between groups (epicardial-alone 73%, CI 62-85%; hybrid 63%, CI 51%-
76%).  We also used this sensitivity analysis to reassess the meta-regression.   Lesion sets more 
extensive than pulmonary vein isolation were not associated with higher success rates (OR 0.99, 
0.77-1.23) even in studies including predominantly persistent AF, and continued to be associated 
with higher complication rates (OR 1.05, 1.00-1.11). 
 As access site and energy source were each associated with success, we assessed the effect of 
including only studies that used thoracoscopic access and bipolar RF.  Despite this, no difference was 
seen in the primary outcome at 12 months (epicardial-alone 73%, CI 67-79%; hybrid 75%, CI 65%-
85%).    
While many studies defined success according to ACC/AHA/ESC guidelines, some used weaker 
definitions such as point prevalence of AF.  Furthermore, some studies performed prolonged periods 
of ambulatory monitoring or implantable loop recorders while others performed little or none.  
Including only studies which explicitly defined success according to ACC/AHA/ESC guidelines28 did 
not reveal any differences in the primary outcome (epicardial-alone 74%, CI 68-81%; hybrid 62%, CI 
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47%-78%), neither did including only studies in which participants underwent >7 days of ambulatory 
monitoring (epicardial-alone 75%, CI 67-84%; hybrid 61%, CI 45%-77%).  Similar results were seen in 
outcomes at 24 months (Supplemental Table 9).    
Having found that a hybrid ablation strategy was associated with higher rates of major 
complications, we assessed the validity of our statistical methods by adjusting the fixed value added 
to series with zero events.  Hybrid ablation was associated with increased complications rates 
without overlap of confidence intervals at a range of added fixed values from 0.05 to 1.  When we 
assessed the complication rate including only studies employing the most effective technique of 
thoracoscopic access and bipolar RF the magnitude of difference in complication rate was similar but 
the lower statistical power rendered the difference non-significant (epicardial-alone 2.8%, CI 1.5-
4.1%; hybrid 6.6%, CI 3.2%-10.0%). 
Study quality and risk of bias 
Studies were generally of variable quality (Figure 3A).  While 6/41 studies met all 8 quality 
assessment criteria, 23 passed 5-7 criteria.  13 studies  met 4 or fewer criteria.  13/41 studies 
reported detailed inclusion and exclusion criteria.  20/41 studies were unrepresentative of usual 
practice, including large proportions of participants with paroxysmal AF.   37/41 studies defined 
outcomes adequately.  28/41 studies reported and explained loss to follow up, and in 8/41 studies 
>10% of patients were lost to follow up. Only 17/41 studies recruited prospectively and 30/41 
recruited consecutive patients.  39/41 studies reported relevant prognostic factors. 
Funnel plots and Egger’s test were used to assess the risk of publication bias.  For studies of 
epicardial ablation alone, Egger’s test suggested a risk of publication bias, although visual 
assessment of the Funnel plot was not unduly concerning (Figure 3B).  For studies of hybrid ablation, 
the risk of publication bias was low (Figure 3C). 
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The numbers of studies meeting all quality inclusion criteria were too small to permit meaningful 
comparisons between groups.     
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Discussion 
The main findings are that: (1) minimally invasive surgical epicardial ablation and hybrid ablation of 
AF are both effective. (2) Success rates are similar between these groups.  (3) Hybrid ablation is 
associated with higher rates of major complications.  (4) Monopolar RF and transdiaphragmatic 
access are associated with lower success rates.  (5) With the exception of left atrial appendage 
exclusion, lesion sets that were more extensive than pulmonary vein isolation are not associated 
with higher success rates. 
Hybrid and epicardial-alone ablation are both effective preventing recurrent AF. 
Similar to previous reviews of minimally invasive surgical ablation of AF, we found that both hybrid 
and epicardial-alone approaches are effective3,29, although our estimates of success of 72% and 63% 
at 12 months and 69% and 57% at 24 months for epicardial-alone and hybrid strategies respectively 
are more conservative than some previous reviews.  Different estimates could arise for several 
reasons.  Firstly, many studies report outcomes at last follow up.  Although mean follow up in these 
groups may exceed 12 months, inclusion of patients with shorter follow up is likely to overestimate 
success rates.  We have reported data at specific timepoints to minimise this bias.  We took great 
care to only include non-overlapping studies, reducing the risk of bias arising from including 
duplicate patients from successful high-volume centres.   We also included deceased patients in the 
follow up denominators for all studies even if these patients were excluded from the headline figure 
in the original manuscripts. 
Hybrid ablation offers little advantage over epicardial ablation alone and is associated with higher 
complication rates 
Hybrid ablation did not offer higher success rates at 12 or 24 months.  No differences were seen 
when all studies were included or when the disparities in operative technique, patient 
demographics, definitions of success, or duration of ambulatory monitoring were controlled for in 
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sensitivity analyses.   Furthermore, even though all patients receiving hybrid ablation underwent at 
least one catheter ablation, the need for additional catheter ablations beyond the planned 
procedure did not decrease with a hybrid strategy.  While no significant difference was seen 
between groups, the numerically lower success rates seen in the hybrid group appear to have been 
driven by those studies which employed transdiaphragmatic access and monopolar RF.  
Metaregression identified transdiaphragmatic access and monopolar RF as being predictive of lower 
success.  In addition, the sensitivity analysis excluding studies which used these techniques showed 
near-identical success rates between hybrid and epicardial-alone ablation.   
Whilst failing to provide a clinical benefit, hybrid ablation was associated with more major 
complications.  The difference in complications was largely driven by more patients suffering from 
major bleeding and pericardial effusions requiring drainage, as expected from the additional vascular 
access and trans-septal puncture obligated by hybrid ablation.  This finding is in keeping with a 
previous systematic review3 which showed that the complication rate from hybrid ablation was 
higher than that seen from the full Cox-Maze ablation performed on cardiopulmonary bypass.  The 
absolute complication rates reported should be interpreted with caution, as the sensitivity analysis 
using only series obtained from arms of randomised trials suggested that complication rates could 
be double that reported amongst the case series as a whole. 
Monopolar RF and transdiaphragmatic access are associated with lower success rates 
Corroborating a previous cohort study30, monopolar RF was less effective than bipolar RF at 
preventing recurrent atrial arrhythmias, potentially because transmural ablation lesions are seen 
less frequently following monopolar than bipolar RF in animal studies8.   Furthermore, 
transdiaphragmatic access was less effective than thoracoscopic access.  This may be partly because 
studies employing transdiaphragmatic access used monopolar RF.  However, as transdiaphragmatic 
access limits ablation of the superior aspects of the pulmonary veins, this technique may impair 
complete pulmonary vein isolation, the cornerstone of successful AF ablation.  Relying on one 
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continuous box lesion to encircle all veins means that failure at even a single point along this long 
ablation line may cause electrical reconnection of all veins.   
Despite these shortcomings, transdiaphragmatic access may have a role for patients with poor 
respiratory reserve for whom the single lung ventilation required for thoracoscopic ablation may be 
hazardous. 
More extensive lesion sets do not increase success rates 
Pulmonary vein isolation alone was as effective as more extensive ablation.  Neither ganglionic 
plexus ablation, creation of a box lesion set, nor right atrial ablation were associated with higher 
success rates at 12 or 24 months.  This supports randomised data from the AFACT study25 showing 
that that the addition of ganglionic plexus ablation to surgical pulmonary vein isolation did not 
improve outcomes.   These findings were consistent across the primary analysis and within a 
sensitivity analysis minimising the inclusion of patients with paroxysmal AF. 
Isolation of the left atrial appendage was associated with greater success at 12 months.  Although a 
similar effect size was found at 24 months, a significant difference was not seen at this timepoint.  
This uncertainty reflects the controversy in the existing literature.  While the BELIEF trial9 suggested 
that LAA electrical isolation decreased AF recurrence following catheter ablation, Romanov et al.26 
found no benefit to LAA ligation during surgical ablation. 
Limitations 
This meta-analysis is based on case series and therefore is at greater risk of bias than randomised 
data.  Furthermore, the majority of studies were graded only moderate in quality.  However, we 
believe that our approach is valid as randomised data are not currently available to answer this 
question.  Moreover, prior meta-analyses of case series in the field of ablation for AF have given 
results consistent with RCTs19.    
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As the data were not sourced from RCTs there are inevitable differences in the demographics 
between study groups.  Hybrid studies included more patients with longstanding persistent AF which 
may underestimate the relative efficacy of hybrid ablation.  However, controlling for these 
differences using a sensitivity analysis including only studies in which <20% of patients had 
paroxysmal AF abolished all differences in baseline demographics without revealing any differences 
in success rates.  Despite this, it is possible that residual unmeasured confounders remain, 
potentially leaving the hybrid ablation group with a patient cohort with more advanced disease and 
hiding a true benefit from this procedure. 
While the mandate for surgical ablation of AF is greatest in patients with longstanding persistent AF, 
our pre-specified primary analysis also included studies with a high prevalence of paroxysmal AF, 
potentially overestimating the success rates of surgical ablation.  However, the sensitivity analysis 
including only studies with <20% paroxysmal AF showed that success rates were similar to those 
when all studies were included.  
The definition of minimally invasive surgery used here included access via thoracoscopy, 
transdiaphragmatic pericardioscopy and mini-thoracotomy.  While some argue that mini-
thoracotomy is not minimally invasive, lengths of stay and rates of complications were similar 
between these three methods (Supplemental Table 9) suggesting that mini-thoractomy is no more 
invasive than other modes of access. 
Complication reporting was highly variable, and underreporting of complications may have been 
present.  To reduce the risk that underreporting might influence a comparison between groups,  the 
definition of major complications used here was relatively narrow, including only the complications 
most likely to be reported.   As a result, the true incidence of complications using a broader 
definition such as the Ottawa Thoracic Morbidity and Mortality classification system31 may be 
higher. 
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Conclusions 
Minimally invasive surgical ablation offers a chance of freedom from the potentially disabling 
symptoms of AF, at least in the medium term.  Epicardial ablation alone appears to be as effective as 
hybrid ablation and may be associated with fewer complications, although complications may have 
been underreported in some case series.  The highest success rates are associated with 
thoracoscopic ablation using bipolar radiofrequency energy including isolation of the left atrial 
appendage.  These analyses, based upon data predominantly from case series of generally moderate 
quality, need to be verified with randomised trials. 
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Figure Legends 
Figure 1 – Study selection diagram. See Supplemental Table 4 for details of all excluded full text 
articles. 
 
Figure 2 – Forest plot showing the primary outcome of atrial arrhythmia-free survival without 
antiarrhythmic drugs at A 12 and B 24 months.  Supplemental references 64-104 * additional data 
obtained following personal communication with authors † Outcome adjusted to include deceased 
patients ‡ Reported as outcome at 13 months.  AADs – antiarrhythmic drugs.  
 
Figure 3- Assessment of study quality and risk of bias.  A  Study quality assessment. Green boxes 
indicate that this study passed this criterion, red boxes indicate failure. B  Funnel plot of studies of 
epicardial ablation alone.  C  Funnel plot of studies of hybrid ablation.  P-values refer to Egger’s test 
of likelihood of publication bias.  
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Tables 
Table 1 
Demographic 
Mean (SD) 
Epicardial alone 
(30 series, 
2132 patients) 
Hybrid 
(12 series, 
605 patients) 
Difference 
(P-value) 
 
Age (years) 
 
59.1 (4.1) 
 
60.5 (2.9) 
 
0.22 
Gender (%) 69.6 (11.6) 76.5 (13.8) 0.16 
LA diameter (mm) 46.0 (4.2) 48.7 (2.8) 0.02 
LV ejection fraction (%) 56.6 (4.4) 54.4 (4.8) 0.24 
BMI (kg/m2) 28.6 (3.0) 29.7 (2.1) 0.35 
CHADS score 1.2 (1.0) 1.2 (0.2) 0.80 
Prior catheter ablation (%) 28.6 (25.9) 28.7 (33.4) 0.99 
Paroxysmal AF (%) 43.6 (33.3) 9.3 (16.1) <0.001 
Persistent AF (%) 30.0 (28.6) 35.7 (30.0) 0.58 
Longstanding persistent AF (%) 26.4 (37.3) 55.2 (34.7) 0.03 
Duration of AF (years) 5.0 (2.1) 5.0 (1.3) 0.99 
Table 1 – Demographics of patients included in studies 
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Table 2 
 12 month success Major Complications 
 Odds ratio (95% CIs) P-value Odds ratio (95% CIs) P-value 
Procedure           
    Epicardial alone 1  1  
    Hybrid 0.92 (0.84,1.02) 0.14 1.03 (1.01,1.05) 0.01 
Access       
    Thoracoscopic 1  1  
    Mini-thoracotomy 0.92 (0.82,1.04) 0.19 0.99 (0.97,1.01) 0.51 
    Transdiaphragmatic 0.72 (0.61,0.86) <0.001 1.05 (1.00,1.11) 0.04 
    Mixed 0.99 (0.80,1.23) 0.9 1.04 (0.98,1.10) 0.09 
Energy Source       
    Bipolar 1  1  
    Monopolar 0.79 (0.70,0.88) <0.001 1.02 (0.98,1.06) 0.18 
    Mixed 0.99 (0.74,1.33) 0.95 1.38 (1.11,1.71) <0.001 
Lesion set category       
    PVI only 1  1  
    PVI + LA Box lesion  1.01 (0.90,1.14) 0.8 1 (0.98,1.02) 0.86 
    PVI + LA Box + RA 
ablation  
0.97 (0.86,1.09) 0.59 1.04 (1.02,1.06) <0.001 
Ganglionic plexus ablation       
    False 1  1  
    True 1.06 (0.96,1.17) 0.21 0.99 (0.97,1.01) 0.4 
Left atrial appendage 
exclusion 
      
    False 1  1  
    True 1.15 (1.04,1.27) 0.01 1.03 (1.01,1.05) 0.02 
Conduction block checked       
28 
 
 
    False 1  1  
    True 1.02 (0.87,1.19) 0.78 1 (0.96,1.04) 0.84 
Duration of ambulatory 
monitoring  
      
    < 48 hours 1  1  
48    hours – 7 days 0.98 (0.84,1.15) 0.81 1.01 (0.97,1.05) 0.43 
    > 7 days 0.99 (0.85,1.16) 0.95 1.02 (0.98,1.06) 0.33 
Prevalence of paroxysmal 
AF 
1.03 (0.92,1.16) 0.63 0.98 (0.96,1.00) 0.1 
Table 2 - Meta-regression.  CI – confidence intervals, PVI – pulmonary vein isolation, LA – left 
atrial, RA – right atrial. 
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